A phase I study of bevacizumab (BV) plus ABT-510 in patients with advanced solid tumors

被引：0
|
作者：
Uronis, H. E. [1 ]
Bendell, J. [1 ]
Blobe, G. [1 ]
Morse, M. [1 ]
Geier, D. [1 ]
Nixon, A. [1 ]
Howard, L. [1 ]
Evans, D. [1 ]
Li, H. [1 ]
Hurwitz, H. [1 ]
机构：
[1] Duke Univ, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3541
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I study of ABT-510 plus bevacizumab in advanced solid tumors
    Uronis, Hope E.
    Cushman, Stephanie M.
    Bendell, Johanna C.
    Blobe, Gerard C.
    Morse, Michael A.
    Nixon, Andrew B.
    Dellinger, Andrew
    Starr, Mark D.
    Li, Haiyan
    Meadows, Kellen
    Gockerman, Jon
    Pang, Herbert
    Hurwitz, Herbert I.
    CANCER MEDICINE, 2013, 2 (03): : 316 - 324
  • [2] A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid Tumors
    Rini, Brian I.
    Garcia, Jorge A.
    Cooney, Matthew M.
    Elson, Paul
    Tyler, Allison
    Beatty, Kristi
    Bokar, Joseph
    Mekhail, Tarek
    Bukowski, R. M.
    Budd, G. Thomas
    Triozzi, Pierre
    Borden, Ernest
    Ivy, Percy
    Chen, Helen X.
    Dolwati, Afshin
    Dreicer, Robert
    CLINICAL CANCER RESEARCH, 2009, 15 (19) : 6277 - 6283
  • [3] Phase 2 study of ABT-510 in patients with previously untreated advanced renal cell carcinoma
    Ebbinghaus, Scot
    Hussain, Maha
    Tannir, Nizar
    Gordon, Michael
    Desai, Apurva A.
    Knight, Raymond A.
    Humerickhouse, Rod A.
    Qian, Jiang
    Gordon, Gary B.
    Figlin, Robert
    CLINICAL CANCER RESEARCH, 2007, 13 (22) : 6689 - 6695
  • [4] Preliminary results of a phase I study of bevacizumab (BV) in combination with everolimus (E) in patients with advanced solid tumors
    Bendell, J.
    Lager, J.
    Zafar, Y.
    Yu, D.
    George, D.
    Nixon, A.
    Petros, W.
    Arrowood, C.
    Beci, R.
    Hurwitz, H.
    ANNALS OF ONCOLOGY, 2006, 17 : 67 - 67
  • [5] Results of a phase I study of bevacizumab (BV), everolimus (EV), and erlotinib (E) in patients with advanced solid tumors
    Bendell, J. C.
    George, D.
    Nixon, A.
    Yu, D.
    Petros, W.
    Beci, R.
    Arrowood, C.
    Lockamy, D.
    O'Neill, M.
    Hurwitz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors
    Gietema, J. A.
    Hoekstra, R.
    de Vos, F. Y. F. L.
    Uges, D. R. A.
    van der Gaast, A.
    Groen, H. J. M.
    Loos, W. J.
    Knight, R. A.
    Carr, R. A.
    Humerickhouse, R. A.
    Eskens, F. A. L. M.
    ANNALS OF ONCOLOGY, 2006, 17 (08) : 1320 - 1327
  • [7] A phase I dose escalating study of the angiogenesis inhibitor thrombospondin-1 mimetic (ABT-510) in patients with advanced cancer
    de Vos, FYFL
    Hoekstra, R
    Gietema, JA
    Jager, PJ
    Eskens, FALM
    Carr, R
    Guirguis, M
    Humerickhouse, R
    de Vries, EGE
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S78 - S79
  • [8] Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer
    Hoekstra, R
    de Vos, FYFL
    Eskens, FALM
    Gietema, JA
    van der Gaast, A
    Groen, HJM
    Knight, RA
    Carr, RA
    Humerickhouse, RA
    Verweij, J
    de Vries, EGE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5188 - 5197
  • [9] Preliminary results of a phase I study of bevacizumab (BV) in combination with everolimus (E) in patients with advanced solid tumors.
    Zafar, Y.
    Bendell, J.
    Lager, J.
    Yu, D.
    George, D.
    Nixon, A.
    Petros, W.
    Beci, R.
    Arrowood, C.
    Hurwitz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 145S - 145S
  • [10] Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors
    Lin, Chia-Chi
    Calvo, Emiliano
    Papadopoulos, Kyriakos P.
    Patnaik, Amita
    Sarantopoulos, John
    Mita, Alain C.
    Preston, Glenn G.
    Mita, Monica M.
    Rodon, Jordi
    Mays, Theresa
    Yeh, I-Tien
    O'Rourke, Pat
    Takimoto, Chris H.
    Dancey, Janet E.
    Chen, Helen
    Tolcher, Anthony W.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1065 - 1071
12345